Non-medical Prescribing in the United Kingdom
von: Penelope Mary Franklin
Springer-Verlag, 2017
ISBN: 9783319533247
Sprache: Englisch
236 Seiten, Download: 2663 KB
Format: PDF, auch als Online-Lesen
Foreword | 5 | ||
Acknowledgement | 7 | ||
Contents | 8 | ||
List of Abbreviations | 10 | ||
Chapter 1: Introduction to Non-medical Prescribing: An Overview—Including Non-medical Prescribing in England | 13 | ||
1.1 Purpose of This Book | 14 | ||
1.2 Historical Perspective | 15 | ||
1.3 History Across the Four Countries | 21 | ||
1.4 Where We Are Now and Where We Are Going | 21 | ||
1.5 Continuing Professional Development (CPD) | 22 | ||
1.6 Training and Assessment | 23 | ||
References | 24 | ||
Part I: Non-medical Prescribing in Scotland, Wales and Northern Ireland | 26 | ||
Chapter 2: Non-medical Prescribing in Scotland | 27 | ||
References | 37 | ||
Chapter 3: Non-medical Prescribing in Wales: Implementation and Governance | 42 | ||
3.1 Implementation of Non-medical Prescribing: Nurse Prescribing Formulary | 43 | ||
3.2 Implementation of Supplementary Prescribing: Wales Context | 44 | ||
3.3 Implementation of Independent Prescribing: Wales Context | 47 | ||
3.4 Audit and Monitoring of Prescribing Data in Wales | 52 | ||
3.5 Clinical Governance: Continuing Professional Development | 54 | ||
3.6 Summary | 56 | ||
References | 58 | ||
Chapter 4: Non-medical Prescribing in Northern Ireland | 61 | ||
4.1 Introduction | 63 | ||
4.2 Supplementary Prescribing | 65 | ||
4.3 Curriculum and Training | 66 | ||
4.4 Scope of Practice | 68 | ||
4.5 Independent Prescribing | 69 | ||
4.6 Curriculum and Training | 70 | ||
4.7 Scope of Practice | 74 | ||
4.8 Current Status in Primary and Secondary Care for Pharmacist Prescribers | 75 | ||
4.9 Current Status in Primary and Secondary Care for Nurse Prescribers | 84 | ||
4.10 Current Status in Primary and Secondary Care for Optometrist Prescribers | 85 | ||
4.11 Current Status in Primary and Secondary Care for Allied Health Professionals (Physiotherapist/Podiatrist or Chiropodist/Radiographer) | 88 | ||
4.12 The Future of Non-medical Prescribing in NI | 89 | ||
References | 93 | ||
Part II: Non-medical Prescribing by Pharmacists and Allied Health Professionals | 98 | ||
Chapter 5: Non-medical Prescribing by Pharmacists | 99 | ||
5.1 Genesis | 100 | ||
5.2 Implementation and Its Challenges | 104 | ||
5.3 Minor Ailments Schemes | 110 | ||
5.4 Pharmacists in GP Practices | 114 | ||
References | 115 | ||
Chapter 6: Prescribing by Designated Allied Health Professionals: The AHP Experience | 117 | ||
6.1 Introduction | 118 | ||
6.2 The Allied Health Professions | 118 | ||
6.3 Allied Health Independent Prescribing: Physiotherapy, Podiatry and Therapeutic Radiography | 120 | ||
6.4 Podiatry and Physiotherapy: Current Issues | 121 | ||
6.5 Independent Prescribing in Practice: Key Advantages | 123 | ||
6.6 Independent Prescribing in Practice: Disadvantages | 124 | ||
6.7 Radiography: Current Issues | 125 | ||
6.8 Undergraduate Education in Allied Health Prescribing: A Future Scenario? | 128 | ||
6.9 Conclusion | 129 | ||
References | 130 | ||
Part III: The Practice, Art and Discipline(s) of Non-medical Prescribing | 132 | ||
Chapter 7: The Identity of Non-medical Prescribers | 133 | ||
7.1 Introduction | 134 | ||
7.2 Local Context | 136 | ||
7.3 Social Photo-Matrix | 137 | ||
7.4 Accountability and Governance | 138 | ||
7.5 Medicines Optimisation | 139 | ||
7.6 Therapeutic Relationship | 140 | ||
7.7 Community/Hospital Prescribing | 142 | ||
References | 144 | ||
Chapter 8: Non-medical Prescribing in Community Settings | 146 | ||
8.1 Introduction | 147 | ||
8.2 Medicines Optimisation | 148 | ||
8.3 Mobile Working | 150 | ||
8.4 Community Formulary Prescribing by Specialist Community Public Health Nurses (SCPHNs) | 152 | ||
8.5 Decision Making in Community Nursing | 155 | ||
8.6 Managing Long-Term Conditions in the Community | 156 | ||
8.7 Conclusion | 157 | ||
References | 158 | ||
Chapter 9: Prescribing for Long-Term Conditions | 160 | ||
9.1 Introduction | 161 | ||
9.2 Compassion in Prescribing Practice | 162 | ||
9.3 The Consultation | 165 | ||
9.4 Compliance, Adherence, and Concordance | 169 | ||
9.5 Polypharmacy and De-prescribing | 171 | ||
References | 175 | ||
Chapter 10: Non-medical Prescribing in the Acute Setting | 177 | ||
10.1 Introduction | 178 | ||
10.1.1 The Development of Non-medical Prescribing Within a Hospital at Night Team | 178 | ||
10.2 Accountability, Liability and Prescribing Formularies | 180 | ||
10.3 When Not to Prescribe | 181 | ||
10.4 Remote Prescribing | 182 | ||
10.5 NMP in the Acute Setting | 183 | ||
10.5.1 Case Study One | 183 | ||
10.5.2 Case Study Two | 184 | ||
10.6 Shared Care, Communication and the Importance of Good Documentation | 186 | ||
10.7 Safe Practice | 187 | ||
10.8 Audit and CPD | 188 | ||
10.9 A Personal Audit of NMP Practice | 189 | ||
10.10 Personal CPD Strategy | 191 | ||
10.11 Conclusion | 192 | ||
References | 192 | ||
Chapter 11: Non-medical Prescribers Within Substance Misuse Services | 194 | ||
11.1 Moving Forward with Ambition | 195 | ||
References | 209 | ||
Chapter 12: Non-medical Prescribing in Palliative and End-of-Life Care (EOLC) | 214 | ||
12.1 Introduction: Background to Palliative and EOLC | 215 | ||
12.2 What the Literature Says | 218 | ||
12.3 The Role of the Clinical Nurse Specialist in Palliative Care | 223 | ||
12.4 Hospice | 224 | ||
12.5 Community | 225 | ||
12.6 Maintaining Training: Training and Support for NMPs | 226 | ||
12.7 Case Studies | 227 | ||
12.7.1 Scenario 1 | 227 | ||
12.7.1.1 The Benefits of NMP | 228 | ||
12.7.2 Scenario 2 | 228 | ||
12.7.2.1 The Benefits of NMP | 229 | ||
12.8 Conclusion | 229 | ||
References | 230 | ||
Erratum to: Non-medical Prescribingby Pharmacists | 232 | ||
Index | 233 |